Fundraising FoxRxWare
Wilmington, US · Delaware corporation · 4 known investors
Find your way into RxWare
Sign up to see every warm intro you have to RxWare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RxWare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RxWare is a "Service as a Software" company that uses its AI-powered intelligence engine, RxWare OS, to move patients from prescription to first fill by providing real-time visibility and coordinated intervention across the patient access journey. It serves small to mid-size pharmaceutical manufacturers with specialty or rare disease products, targeting brand and patient access directors.
Founders & leadership
RL
Raeanna LewarneExecutive
SA
Shlomi AflaloExecutive
OK
Ori KarevNamed on SEC filing
YK
Yishai KnobelNamed on SEC filing
Board
AF
GD
Gregg DearhammerBoard director
DM
HT
Harry TotonisBoard director
Investors · 4
Vodia Ventureslisted by Vodia VenturesNew York
How we know: Vodia Ventures's portfolio page · Not right? Tell us
StartUp HealthreportedNew York
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.7M disclosed across 4 rounds · 2019–2025
▶$6.1MraisedAug 2025 · 12 investors · Other Health CareRule 506(b)
▶$6.1MraisedAug 2025 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David MatiasDirector
- Raeanna LewarneExecutive Officer, Director
- Shlomi AflaloExecutive Officer, Director
- Harry TotonisDirector
- Farhan AshrafDirector
- Adam FineDirector
- Offering amount
- $6.7M
- Amount sold
- $6.1M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$225KraisedDec 2024 · 3 investors · Other Health CareRule 506(b)
▶$225KraisedDec 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregg DearhammerDirector
- Adam FineDirector
- David MatiasDirector
- Harry TotonisDirector
- Raeanna LewarneExecutive Officer, Director
- Shlomi AflaloExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $225K
- Proceeds to insiders
- $27K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedMay 2024 · 4 investors · Other Health CareRule 506(b)
▶$700KraisedMay 2024 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David MatiasDirector
- Raeanna LewarneExecutive Officer
- Gregg DearhammerDirector
- Adam FineDirector
- Shlomi AflaloExecutive Officer, Director
- Harry TotonisDirector
- Aaron GanzExecutive Officer
- Offering amount
- $1M
- Amount sold
- $700K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedOct 2019 · 4 investors · Other Health CareRule 506(b)
▶$3.6MraisedOct 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregg DearhammerDirector
- Shlomi AflaloExecutive Officer, Director
- Adam E. FineDirector
- Ori KarevDirector
- Yishai KnobelExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3.6M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
MarketwareMarketware provides a platform suite for healthcare organizations to manage physician relations, recruitment, analytics, and onboarding across the provider lifecycle. The integrated software helps hospitals and health systems reduce referral leakage, improve provider engagement, and streamline growth operations through data-driven workflows.
PathwarePathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries. The company serves pathology practices and healthcare systems performing diagnostic biopsies.
Companies working in the same space as RxWare.
Frequently asked questions
- What does RxWare do?
- RxWare is a "Service as a Software" company that uses its AI-powered intelligence engine, RxWare OS, to move patients from prescription to first fill by providing real-time visibility and coordinated intervention across the patient access journey. It serves small to mid-size pharmaceutical manufacturers with specialty or rare disease products, targeting brand and patient access directors.
- Who are RxWare's investors?
- RxWare's investors include Vodia Ventures, Windham Capital Partners, ZORA, StartUp Health.
- How much funding has RxWare raised?
- RxWare has disclosed $10.7M raised across 4 rounds.
- Where is RxWare headquartered?
- RxWare is headquartered in Wilmington, US.